Introduction {#sec1-1}
============

Urinothorax, an accumulation of urine in the pleural space, is a rare and unusual cause of a pleural effusion with \<100 reported cases in the literature.\[[@ref1]\] This is seen in patients with obstructive uropathy,\[[@ref2][@ref3][@ref4]\] blunt abdominal trauma,\[[@ref5][@ref6][@ref7]\] and percutaneous renal and ureteral procedures.\[[@ref8]\] Pleural fluid analysis obtained through thoracentesis offers the diagnosis for urinothorax by measurement of creatinine and calculating the ratio of pleural fluid creatinine relative to serum creatinine, with a value \>1 indicative for urinothorax.\[[@ref9]\] Understanding diagnostic features, different treatment options, and outcomes will help in early diagnosis and therapeutic intervention for urinothorax. We present here a case of urinothorax after percutaneous nephrostolithotomy, which did not resolve with thoracostomy and chest tube placement until the underlying urological etiology was discovered and addressed. This case underlines the importance of utilizing imaging and interventional procedures to correct the underlying problem.

Case Report {#sec1-2}
===========

A 57-year-old female with past medical history of thyroid cancer status postthyroidectomy, kidney stones, and chronic kidney disease presented to the emergency department with acute onset of shortness of breath, fever, and left-sided chest pain. The chest pain had progressively worsened over the past 3 days.

The patient underwent left nephrolithotomy 7 days prior for symptomatic renal calculi with insertion of a left nephrostomy tube and its removal 5 days later. The patient was taking sulfamethoxazole--trimethoprim (double strength) and phenazopyridine at presentation.

The patient was visibly in pain breathing 18 breaths/min with an oxygen saturation of 92% on room air and normal remaining vital signs. Examination demonstrated decreased breath sounds and dullness to percussion over the lower two-thirds of the left chest.

Laboratory work showed an unremarkable CBC. Blood urea nitrogen was 24 mg/dL, serum creatinine was 1.19 mg/dL (patient\'s baseline was 0.65 mg/dL), and glomerular filtration rate was calculated to be 47 ml/min/1.73 m^2^ (patient\'s baseline was 90 ml/min/1.73 m^2^). Urinalysis showed positive nitrites, positive leukocyte esterase, 1 + bacteria, 28 leukocytes, and 37 epithelial squamous cells. The urine was orange in color consistent with phenazopyridine treatment. Chest radiograph revealed a significant left pleural effusion \[[Figure 1](#F1){ref-type="fig"}\].
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A chest tube was placed through the left fourth intercostal space, and 2 L of fluid was removed. The fluid was yellow and blood tinged, with an odor and appearance resembling urine. The fluid analysis revealed a leukocyte count of 2060/μL, pH of 6.69, glucose of 104 mg/dL, protein of \< 2 g/dL, lactate dehydrogenase (LDH) of 342 U/L, and creatinine of 5.50 mg/dl. The pleural fluid creatinine to serum creatinine ratio was 4.6. Fluid cultures and cytology were negative. Based on the appearance of the pleural fluid and the elevated serum to fluid creatinine ratio, the patient was diagnosed with urinothorax.

The patient was initially managed conservatively with a chest tube and catheter placement; however, the chest tube fluid output persisted, so a cystoscopy with left retrograde pyelogram was performed that revealed a narrowing in the ureter orifice, and subsequently, a left ureteral stent was placed. After the procedure, the chest tube output decreased significantly, urine output improved, and the patient\'s symptoms resolved within few days.

Discussion {#sec1-3}
==========

A rare and unusual etiology of a pleural effusion is an urinothorax, which is urine accumulation in the pleural space. The development of urinothorax is hypothesized to occur as a result of one of two different mechanisms: direct passage of urine through an anatomical defect in the diaphragm or by diaphragmatic lymphatics through the retroperitoneal space.\[[@ref10]\]

Interestingly, our patient was taking phenazopyridine, which was evident by the typical orange discoloration of the urine but not the pleural fluid. This favors an indirect passage of urine into the pleural cavity instead of through a direct defect in the diaphragm. The exact mechanism by which the orange discoloration did not follow the urine into the chest is unknown, and to the best of our knowledge, this is the first report of this kind.

Pleural fluid analysis confirms the diagnosis of urinothorax in most cases. Previously reported diagnostic criteria were used in this case including a pleural fluid creatinine to serum creatinine ratio \>1.0 and a low pleural fluid pH.\[[@ref11]\] A typical urinothorax will have the characteristics of transudate per Light\'s criteria. However, an urinothorax may have an elevated LDH level, and therefore, the effusion may be interpreted as an exudate. This was seen in our patient, and to the best of our knowledge, only few other cases have reported an exudative pleural effusion.\[[@ref9][@ref12][@ref13]\]

Imaging is often used to confirm the pleural effusion collection as well as the underlying process. X-rays, renal scans, contrast-enhanced computed tomography, and pyelograms may all be used to establish the location of the urine leakage.

Treatment of an urinothorax involves evacuation of the fluid from the pleural space and correction of the underlying deficit in the urinary tract. Thoracentesis or thoracostomy is typically used to evacuate the pleural fluid. Treatment of the underlying cause is based on the mechanism of injury and may involve ureteral stenting or surgery.\[[@ref14][@ref15]\] Urinothorax, although rare, may be underdiagnosed, and therefore, it is important to have a high index of suspicion in patients with unknown cause of pleural effusion and recent history of urological pathology or procedure. These cases typically need a consult to urology, and awareness is important for an early diagnosis and treatment.
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